Suad Aljohani

Dr. Suad Aljohani

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2010 in The American Journal of Medicine
Verified
Journal Article
Closed access
SFStefano Fedele
Stefano Fedele
SPStephen Porter
Stephen Porter
FDFrancesco D'Aiuto
Francesco D'Aiuto
SASuad Aljohani
Suad Aljohani
PVPaolo Vescovi
Paolo Vescovi
NYNaom Yarom
Naom Yarom

1 September 2017 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
SASuad Aljohani
Suad Aljohani
RFRiham M Fliefel
Riham M Fliefel
JIJacob Ihbe
Jacob Ihbe
JKJan Kühnisch
Jan Kühnisch
MEMichael Ehrenfeld
Michael Ehrenfeld
SOSven Otto
Sven Otto

9 May 2021 in Medicina
Verified
Journal Article
Open access
PDF file
SOSven Otto
Sven Otto
SASuad Aljohani
Suad Aljohani
RFRiham M Fliefel
Riham M Fliefel
SESara Ecke
Sara Ecke
OROliver Ristow
Oliver Ristow
MEMichael Ehrenfeld
Michael Ehrenfeld
Medication-related osteonecrosis of the jaw (MRONJ) has become a well-known side effect of antiresorptive, and antiangiogenic drugs commonly used in cancer management. Despite a considerable amount of literature addressing MRONJ, it is still widely accepted that the underlying pathomechanism of MRONJ is unclear. However, several clinical and preclinical studies indicate that infection seems to have a major role in the pathogenesis of MRONJ. Although there is no conclusive evidence for the infection hypothesis yet, available data have shown a robust association between local infection and MRONJ development. This observation is very critical in order to implement policies to reduce the risk of MRONJ in patients under antiresorptive drugs. This critical review was conducted to collect the most reliable evidence regarding the link between local infection and MRONJ pathogenesis.

1 September 2018 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
SASuad Aljohani
Suad Aljohani
RGRobert Gaudin
Robert Gaudin
JWJulian Weiser
Julian Weiser
MTMatthias Tröltzsch
Matthias Tröltzsch
MEMichael Ehrenfeld
Michael Ehrenfeld
SOSven Otto
Sven Otto

30 October 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
NBNada Binmadi
Nada Binmadi
MAmaha alsharif
maha alsharif
SASoulafa A. Almazrooa
Soulafa A. Almazrooa
SASuad Aljohani
Suad Aljohani
SASara Akeel
Sara Akeel
YMYasmin Mair
Yasmin Mair
(1) Objectives: This systematic review and meta-analysis aimed to summarize current evidence regarding the prognostic role of perineural invasion (PNI) in patients with oral squamous cell carcinoma (OSCC). (2) Methods: We searched Cochrane Central, ProQuest, PubMed, Scopus, Science Direct, and Web of Science, using relevant keywords to identify eligible articles. Two independent reviewers conducted two-stage screening, data extraction, and quality assessment. The risk of bias was assessed using the Newcastle–Ottawa Scale (NOS) criteria. All analyses were performed using comprehensive meta-analysis (CMA; version 3.3.070) software. (3) Results: The study included 101 published articles encompassing 26,062 patients. The pooled analyses showed that PNI was associated with significantly worse overall survival (OS; HR = 1.45, 95% CI: 1.32–1.58; p < 0.001), worse disease-specific survival (DSS; HR = 1.87, 95% CI: 1.65–2.12; p < 0.001), and worse disease-free survival (DFS; HR = 1.87, 95% CI: 1.65–2.12; p < 0.001). Similarly, both local recurrence-free survival (LRFS) and regional recurrence-free survival (RRFS) were worse in patients with PNI (HR = 2.31, 95% CI: 1.72–3.10, p < 0.001; and HR = 2.04, 95% CI: 1.51–2.74, p < 0.001), respectively. The random-effect estimate of three studies demonstrated that the presence of PNI was associated with worse failure-free survival (FFS; HR = 2.59, 95% CI: 1.12–5.98, p < 0.001). (4) Conclusions: The current evidence suggests that PNI can be used as an independent predictor of the prognosis for patients with OSCC. The presence of PNI was associated with worse OS, DFS, DSS, FFS, and with recurrence. Asian patients and patients with extra-tumoral or peripheral PNI invasion were associated with worse prognosis.

16 October 2018 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
SASuad Aljohani
Suad Aljohani
MTMatthias Troeltzsch
Matthias Troeltzsch
SHSigurd Hafner
Sigurd Hafner
GKGabriele Kaeppler
Gabriele Kaeppler
GMGerson Mast
Gerson Mast
SOSven Otto
Sven Otto